Abstract
Background: Objectives: To estimate the significance of the central role of the immunological marker IL-21 level and know the interaction between TNF inhibitors and IL-21 with susceptibility to rheumatoid arthritis (RA) sickness. Material and Methods: Serum testers were obtained from three distinct categories: the initial group consisted of those sick and diagnosed with RA who were undergoing treatment with TNF inhibitors, the second group included individuals who were recently diagnosed with RA, and the third group comprised healthy volunteers. The serum from this sample was utilized for quantifying the levels of IL-21 using the ELISA technique. Result: The level of serum IL-21 stood higher in RA under treatment with TNF inhibitors in comparison with further groups, and the variance was greatly important (P = 0.295). Conclusion: On the foundation of the existing training, levels of serum IL-21 were higher in RA under treatment with TNF inhibitors in rapprochement with further groups, and the variance stayed greatly important.
Article Type
Article
First Page
34
Last Page
38
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Recommended Citation
Shaker, Maryam Yaseen and Shaheed, Orass Madhi
(2026)
"Interaction between TNF Inhibitors and Serum IL21Levels with Susceptibility to Rheumatoid Arthritis,"
Al-Qadisiyah Medical Journal: Vol. 22:
Iss.
1, Article 6.
DOI: https://doi.org/10.28922/2312-7864.1704
